Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPPET: Plasma-derived vs Recombinant FVIII in Hemophilia A
NCT01064284Phase 4Completed
- Sponsor
- Fondazione Angelo Bianchi Bonomi
- Start
- Jan 2010
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 4 trial of plasma-derived factor VIII, recombinant human coagulation factor VIII in hemophilia A, sponsored by Fondazione Angelo Bianchi Bonomi. Started Jan 2010; status: completed.
02
Drugs
plasma-derived factor VIIIrecombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01064284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064284.